Munich - Delayed Quote EUR
Tvardi Therapeutics Inc. R (69C.MU)
16.88
+0.74
+(4.56%)
At close: April 24 at 8:23:53 AM GMT+2
Breakdown
TTM
12/31/2023
12/31/2022
Operating Cash Flow
-19,221
-21,040
-17,866
Investing Cash Flow
--
22,468
-22,000
Financing Cash Flow
-9
2
4
End Cash Position
9,438
22,919
21,489
Capital Expenditure
--
--
-50
Issuance of Capital Stock
5
2
4
Free Cash Flow
-19,221
-21,040
-17,916
12/31/2022 - 4/16/2025
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
SCP.F Scancell Holdings plc
0.1060
+4.95%
6XP.SG Xspray Pharma AB (publ)
3.4000
+4.29%
1T3.F Syndax Pharmaceuticals, Inc.
11.20
0.00%
7UM0.F Zelluna ASA
1.2760
-2.60%
0M4.F Mersana Therapeutics, Inc.
0.2879
-1.61%
GBM.F Inovio Pharmaceuticals, Inc.
1.6200
0.00%
5CV.DE CureVac N.V.
2.8580
+0.42%
GNTA Genenta Science S.p.A.
3.9200
+2.62%
ELDN Eledon Pharmaceuticals, Inc.
3.3600
0.00%
TRVI Trevi Therapeutics, Inc.
6.35
+1.28%